PS as discussed, I'm happy to give BAT management some heat directly on the RCF funding package and argue the toss about how it could/can be done better, but I'm not dying in a ditch.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025